These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 945126

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective.
    Friedman OM, Wodinsky I, Myles A.
    Cancer Treat Rep; 1976 Apr; 60(4):337-46. PubMed ID: 1277209
    [Abstract] [Full Text] [Related]

  • 3. Cytostatic effect of homo-aza-steroidal esters in vivo and in vitro. Structure-activity relationships.
    Catsoulacos P, Camoutsis C, Papageorgiou A, Adamiak-Margariti E.
    Anticancer Res; 1992 Apr; 12(5):1617-20. PubMed ID: 1444229
    [Abstract] [Full Text] [Related]

  • 4. Cyclic phosphoramide mustard (NSC-69945) derivatives of amino acids and peptides.
    Szekerke M.
    Cancer Treat Rep; 1976 Apr; 60(4):347-54. PubMed ID: 1277210
    [Abstract] [Full Text] [Related]

  • 5. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
    Ramonas LM, Erickson LC, Ringsdorf H, Zaharko DS.
    Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antitumor activity of amidoximes (hydroxyurea analogs) in murine tumor systems.
    Flora KP, van't Riet B, Wampler GL.
    Cancer Res; 1978 May; 38(5):1291-5. PubMed ID: 639062
    [Abstract] [Full Text] [Related]

  • 9. Studies on 4-hydroperoxycyclophosphamide (NSC-181815): a simple preparation method and its application for the synthesis of a new class of "activated" sulfur-containing cyclophosphamide (NSC-26271) derivatives.
    Peter G, Wagner T, Hohorst HJ.
    Cancer Treat Rep; 1976 Apr; 60(4):429-35. PubMed ID: 1277218
    [Abstract] [Full Text] [Related]

  • 10. Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agent.
    Hickman JA, Stevens MF, Gibson NW, Langdon SP, Fizames C, Lavelle F, Atassi G, Lunt E, Tilson RM.
    Cancer Res; 1985 Jul; 45(7):3008-13. PubMed ID: 4005840
    [Abstract] [Full Text] [Related]

  • 11. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity.
    Finch RA, Shyam K, Penketh PG, Sartorelli AC.
    Cancer Res; 2001 Apr 01; 61(7):3033-8. PubMed ID: 11306484
    [Abstract] [Full Text] [Related]

  • 12. Comparative pharmacologic study in vitro and in vivo with cyclophosphamide (NSC-26271), cyclophosphamide metabolites, and plain nitrogen mustard compounds.
    Brock N.
    Cancer Treat Rep; 1976 Apr 01; 60(4):301-8. PubMed ID: 1277205
    [Abstract] [Full Text] [Related]

  • 13. Antitumor activity of 2-chloroethyl (methylsulfonyl)methanesulfonate (clomesone, NSC 33847) against selected tumor systems in mice.
    Dykes DJ, Waud WR, Harrison SD, Laster WR, Griswold DP, Shealy YF, Montgomery JA.
    Cancer Res; 1989 Mar 01; 49(5):1182-6. PubMed ID: 2537144
    [Abstract] [Full Text] [Related]

  • 14. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro.
    Erickson LC, Ramonas LM, Zaharko DS, Kohn KW.
    Cancer Res; 1980 Nov 01; 40(11):4216-20. PubMed ID: 7471062
    [Abstract] [Full Text] [Related]

  • 15. Stereochemistry, metabolism, and antitumor activity of 4-hydroperoxyisophosphamide (NSC-227114) and its stereoisomer.
    Takamizawa A, Iwata T, Yamaguchi K, Shiratori O, Harada M.
    Cancer Treat Rep; 1976 Apr 01; 60(4):361-8. PubMed ID: 1277212
    [Abstract] [Full Text] [Related]

  • 16. The use of deuterated analogs in qualitative and quantitative investigations of the metabolism of cyclophosphamide (NSC-26271).
    Cox PJ, Farmer PB, Foster AB, Gilby ED, Jarman M.
    Cancer Treat Rep; 1976 Apr 01; 60(4):483-91. PubMed ID: 1277225
    [Abstract] [Full Text] [Related]

  • 17. Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.
    Struck RF, Dykes DJ, Corbett TH, Suling WJ, Trader MW.
    Br J Cancer; 1983 Jan 01; 47(1):15-26. PubMed ID: 6821629
    [Abstract] [Full Text] [Related]

  • 18. Cross-linking of DNA in L1210 cells and nuclei treated with cyclophosphamide and phosphoramide mustard.
    Surya YA, Rosenfeld JM, Hillcoat BL.
    Cancer Treat Rep; 1978 Jan 01; 62(1):23-9. PubMed ID: 564237
    [Abstract] [Full Text] [Related]

  • 19. Conjugated system of homo-aza-steroidal esters in cancer chemotherapy.
    Catsoulacos P, Catsoulacos D.
    Anticancer Res; 1994 Jan 01; 14(6B):2525-8. PubMed ID: 7872677
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.